C12N 2795/14211
Microviridae
C12N2795/14211 (Microviridae) appears on 15 US grants and 22 published applications in this corpus.
Search patents in C12N- Granted patents
- 15
- Published applications
- 22
- Assignees
- 15
- Inventors
- 49
- Latest grant
- 8 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 2 |
| 2017 | 0 | 0 |
| 2018 | 2 | 3 |
| 2019 | 2 | 1 |
| 2020 | 3 | 0 |
| 2021 | 0 | 3 |
| 2022 | 0 | 2 |
| 2023 | 0 | 0 |
| 2024 | 0 | 3 |
| 2025 | 2 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2795/14222New viral proteins or individual genes, new structural or functional aspects ofIndexing code5
- C12N 2795/14251Methods of production or purification of viral materialIndexing code5
- C12N 2795/14221Viruses as suchIndexing code2
- C12N 2795/14232Use of virus as therapeutic agent, other than vaccineIndexing code2
- C12N 2795/14261Methods of inactivation or attenuationIndexing code1
- C12N 2795/14223Virus like particles [vlp]Indexing code0
- C12N 2795/14231Uses of virus other than therapeutic or vaccineIndexing code0
- C12N 2795/14233Use of viral protein as therapeutic agent other than vaccineIndexing code0
Recent patents
- Programmable bacteria for the treatment of cancer8 Jul 2025US 12,350,297 B2National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS)
- System and method to determine critical process parameters for a continuous viral inactivation reactor to design and manufacture same28 Jan 2025US 12,209,257 B2Boehringer Ingelheim International GmbH
- Product for cleaning, sanitizing and hygienization16 Jun 2020US 10,683,470 B2Copma S. C. A. R. L.
- Adsorptive membranes for trapping viruses31 Mar 2020US 10,604,742 B2Wisconsin Alumni Research Foundation
- Fed-batch process for the production of bacterial ghosts7 Jan 2020US 10,526,574 B2Bird-C GmbH
- Programmable Bacteria for the Treatment of Cancer8 Jan 2026US 2026/0007703 A1The Trustees of Columbia University in the City of New York
- System and method to determine critical process parameters for a continuous viral inactivation reactor to design and manufacture same10 Apr 2025US 2025/0115882 A1Boehringer Ingelheim International GmbH
- Compositions and methods targeting filamentous bacteriophage3 Oct 2024US 2024/0325517 A1Inimmune Corporation
- Viral filtration media, articles, and methods27 Jun 2024US 2024/0207765 A13M Innovative Properties Company
- Amurins lysins, and lysin-antimicrobial peptide (amp) constructs active against gram-negative bacteria6 Jun 2024US 2024/0181022 A1
Most cited
By later US patents
- Lysogenic bacteriophage isolated from acidophilium8US 5,132,221 AThe United States of America as represented by the United States Department of Energy · 1992
- Method for separating viruses from a contaminant-containing liquid5US 10,315,133 B2Sartorius Stedim Biotech GmbH · 2019
- Adsorptive membranes for trapping viruses5US 9,375,499 B2Wisconsin Alumni Research Foundation · 2016
- Bacteriophage having multiple host range3US 7,163,818 B2The United States of America as represented by the Department of Health and Human Services · 2007
- Adsorptive membranes for trapping viruses2US 9,856,459 B2Wisconsin Alumni Research Foundation · 2018